Body Fluid Collection And Diagnostics Market Size, Share | Report 2022-2030
Fluid samples for diagnostics offer many advantages such as early prognosis, cost effectiveness, and rapid results. They are used to analyze heterogeneous tumors and are also used for the analysis of tumor biomarkers. The ease of collection, storage, and analysis is fueling the demand for adoption of the body fluid collection and diagnostics.
Growing demand for disease diagnostics is positively impacting the growth of the market with novel techniques and products launched by the market players. For instance, in May 2022, TECHKON developed a device and method to analyze fluid samples for the determination of clinical parameters and instant diagnosis of blood, saliva, urine or any such sample on a card that initiates a biochemical reaction or a separation mechanism.
The leveraged demand for the analysis of body fluids in various clinical and diagnostic applications is likely to enhance the demand for instruments used for the collection and analysis of such samples during the forecast period. On the other hand, the increasing incidence of ailments along with numerous clinical trials fosters the growth of kits & reagents used for body fluid collection and diagnostics. For instance, in September 2021, Selux Diagnostics, Inc., declared that its next-generation phenotyping interface secured a designation of ‘breakthrough device’ by the U.S. FDA for analysis of sterile body fluid samples.
Body fluid samples are an abundance of natural biomarker proteins that essentially features the progression of a cancer condition. They are also used for the detection of such biomarkers for confirmation of a cancer condition. For instance, in January 2022, researchers of at the University of Illinois developed a technique to be used for the detection of cancer biomarkers in the body fluid samples. The detection and quantification of cancer-associated molecular biomarkers in such body fluids, are helpful for minimally invasive cancer detection.
The adaptive use of fluid-based tests over biopsy based diagnostic test offers advantages such as minimal invasion and relative ease of sample collection. The analysis of samples such as saliva and urine yield reliable outcomes in the diagnosis of biomarkers for genetic, metabolic, and infectious diseases. For instance, in June 2022, MultiOmic Health collaborated with Mesh Bio to carry out an observational clinical study on chronic metabolic diseases and their increased risk of complications by generating proteomic and metabolomics data from anonymized body fluid samples.
Moreover, the rise in demand for direct-to-consumer testing (DTC) is expected to increase the demand for body fluid collection, to facilitate easy sample collection by consumers. Many players dispatch the DTC sample collection kits directly to the consumers and thereby analyze the collected samples. For instance, in May 2021, Essenlix signed into a collaboration with Roche Diagnostics for deployment of its instant Mobile Self-Test (iMOST) platform to facilitate the patients with at-home testing procedures.
Rise in the incidence of diseases globally and the need for faster diagnosis is likely to positively impact the growth of the market. Body fluids are increasingly used for molecular diagnosis of disease conditions like cancers, genetic disorders, and infectious diseases. For instance, in May 2022, the Hitachi High-Tech Corporation collaborated with Invivoscribe, Inc., for acceleration of molecular diagnostics and precision medicine by integrating Invivoscribe's technology with Hitachi expertise in the analysis of system technologies.
Key Players
Market Segmentation
By Sample Type
By Products
By Technology
By Application
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Body Fluid Collection And Diagnostics Market
5.1. COVID-19 Landscape: Body Fluid Collection And Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Body Fluid Collection And Diagnostics Market, By Sample Type
8.1. Body Fluid Collection And Diagnostics Market, by Sample Type, 2022-2030
8.1.1. Blood
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Saliva
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Urine
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Cerebrospinal Fluid
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Body Fluid Collection And Diagnostics Market, By Products
9.1. Body Fluid Collection And Diagnostics Market, by Products, 2022-2030
9.1.1. Tests/Services
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Kits & Consumables
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Instruments
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Body Fluid Collection And Diagnostics Market, By Technology
10.1. Body Fluid Collection And Diagnostics Market, by Technology, 2022-2030
10.1.1. Next Generation Sequencing (NGS)
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Polymerase Chain Reaction (PCR)
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Fluorescence in situ hybridization (FISH)
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Body Fluid Collection And Diagnostics Market, By Application
11.1. Body Fluid Collection And Diagnostics Market, by Application, 2022-2030
11.1.1. Prognostics & screening
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Diagnostics & monitoring
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Therapeutic decision making
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Body Fluid Collection And Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Products (2017-2030)
12.1.3. Market Revenue and Forecast, by Technology (2017-2030)
12.1.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Products (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Products (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Products (2017-2030)
12.2.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Products (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Products (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Products (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Products (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Products (2017-2030)
12.3.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Products (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Products (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Products (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Products (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Products (2017-2030)
12.4.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Products (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Products (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Products (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Products (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Products (2017-2030)
12.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Products (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Sample Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Products (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Guardant Health
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. QIAGEN N.V.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Johnson & Johnson
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Laboratory Corporation of America Holdings
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Biocept Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. F. Hoffmann-La Roche Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. MDxHealth SA.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers